PI3K inhibition had limited effect on tumor growth in the pancreatic models tested, however, PI3K has well described functions in the tumor stroma of pancreatic cancers, and therefore combined application of a PI3K and a MEK inhibitor might prove beneficial by targeting both tumor cells as well as stromal cells [20]. The gene discussed is MAP2K7; the disease is pancreatic neoplasm.